Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Jun. 30, 2025
Dec. 31, 2024
Current assets:    
Cash $ 111,872 $ 88,033
Accounts receivable, net 51,242 0
Grant receivable 153,728 0
Inventory 133,597 0
Prepaid expenses 77,044 29,963
Total current assets 527,483 117,996
Property and equipment, net 11,083 18,977
Right to use assets 179,555 199,184
Other assets:    
Intangible assets, net 3,080,422 7,848
Goodwill 2,840,400 0
Deposits, long term 41,936 41,936
Total other assets 5,962,758 49,784
Total assets 6,680,879 385,941
Current liabilities:    
Accounts payable and accrued expenses, including related party payables of $1,629,743 and $1,349,465, respectively 11,805,777 5,574,831
Deferred revenue, grant 56,590 56,590
Lease liability, short term 41,686 40,057
Notes payable, net of debt discount of $3,216 and $41,452, respectively 1,546,514 1,343,278
Notes payable, related parties, net of debt discount of $0 and $0, respectively 1,108,559 1,192,859
Total current liabilities 14,559,126 8,207,615
Long term liabilities:    
Economic Injury Disaster loan, long term 70,290 71,029
Upfront purchase price liability 241,662 0
Royalty liability 147,871 0
Royalty obligation, net of discount of $4,184,810 and $4,418,698, related parties 4,537,290 4,303,402
Lease liability, long term 137,869 159,127
Total liabilities 19,694,108 12,741,173
Deficit:    
Common stock, $0.001 par value; 750,000,000 shares authorized, 17,281,886 and 13,299,349 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 17,282 13,299
Common stock subscribed 100,000 100,000
Additional paid in capital 72,520,867 70,953,807
Accumulated deficit (85,283,967) (83,209,142)
Total deficit attributable to BioCorRx Inc. (12,624,202) (12,120,420)
Non-controlling interest (389,027) (234,812)
Total deficit (13,013,229) (12,355,232)
Total liabilities and deficit 6,680,879 385,941
Series A Convertible Preferred Stock [Member]    
Deficit:    
Preferred Stock Value 16,000 16,000
Series B Convertible Preferred Stock [Member]    
Deficit:    
Preferred Stock Value $ 5,616 $ 5,616